Smartleaf Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5K Hold
1,659
﹤0.01% 2153
2026
Q1
$13.4K Buy
1,659
+114
+7% +$1.03K ﹤0.01% 2174
2025
Q4
$10.4K Buy
1,545
+986
+176% +$7.43K ﹤0.01% 2382
2025
Q3
$4.79K Buy
559
+549
+5,490% +$4.27K ﹤0.01% 2391
2025
Q2
$63 Buy
+10
New +$66 ﹤0.01% 2701
2025
Q1
Sell
-95
Closed -$753 2960
2024
Q4
$753 Buy
95
+64
+206% +$617 ﹤0.01% 2717
2024
Q3
$412 Sell
31
-20
-39% -$258 ﹤0.01% 2802
2024
Q2
$654 Buy
+51
New +$513 ﹤0.01% 2501

Other funds holding NVAX

Smartleaf Asset Management's NVAX Position: Q2 2026 in Review

Smartleaf Asset Management held its Novavax (NVAX) position steady in Q2 2026 at 1,659 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

Smartleaf Asset Management first reported a position in NVAX in Q2 2024 and has held it in 8 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Smartleaf Asset Management held 1,659 shares of Novavax worth $15.5K as of Q2 2026.
  • Smartleaf Asset Management left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2153 holding.
  • Smartleaf Asset Management first reported a position in Novavax in Q2 2024 and has held it in 8 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.